U.S. FDA approves Celltrion's STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab)

PRNewswire/ -- Celltrion announced today that the U.S. Food and Drug Administration (FDA) has approved STEQEYMA® (ustekinumab-stba), a...
10 minutes ago
from: PR Newswire

Biosimilar, Celltrion, Food and Drug Administration, Ustekinumab